CD24 polymorphisms in breast cancer: impact on prognosis and risk.

doi:10.1007/s10549-012-2325-9

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

CD24 polymorphisms in breast cancer: impact on prognosis and risk.

Breast cancer research and treatment - 1 Feb 2013

Buck Katharina, Hug Sarah, Seibold Petra, Ferschke Irmgard, Altevogt Peter, Sohn Christof, Schneeweiss Andreas, Burwinkel Barbara, Jäger Dirk, Flesch-Janys Dieter, Chang-Claude Jenny, Marmé Frederik

Abstract excerpt

Overexpression of CD24 has a negative impact on breast cancer prognosis. We have recently reported that the CD24 codon 57 Val/Val genotype (rs52812045) is associated with pathologic complete response after neoadjuvant chemotherapy for primary breast cancer and correlates with intratumoral lymphocyte infiltrates. This study was performed to investigate the influence of CD24 polymorphisms on breast cancer prognosis...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Breast Neoplasms

Share to Case-Control Studies

Share to CD24 Antigen

Share to Neoplasm Staging

Share to Polymorphism, Genetic

Share to Prognosis

Share to Risk

Source

Open in PubMed

Identifiers

PMID: 23314606
DOI: 10.1007/s10549-012-2325-9

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

CD24 polymorphisms in breast cancer: impact on prognosis and risk.PMID 23314606Read ↗

CD24 Ala57Val polymorphism predicts pathologic complete response to sequential anthracycline- and taxane-based neoadjuvant chemotherapy for primary breast cancer.Semantic proximity Read ↗

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast CancerSemantic proximity Read ↗

CD243 gene polymorphism significantly associated with breast cancer susceptibility.Semantic proximity Read ↗

CD24 single nucleotide polymorphisms and cancer risk.Semantic proximity Read ↗

Molecular characterization of CD44+/CD24-/Ck+/CD45- cells in benign and malignant breast lesions.Semantic proximity Read ↗

[Association between CD24 polymorphism and genetic susceptibility to breast cancer: a case-control study].Semantic proximity Read ↗

Toll-like receptor 4 genetic variants and prognosis of breast cancer.Semantic proximity Read ↗

Identification of novel genetic markers of breast cancer survival.Semantic proximity Read ↗

Prognosis assessment of CD44+/CD24- in Breast Cancer Patients: a systematic review and meta-analysisSemantic proximity Read ↗

PD-L1 Gene Polymorphisms rs822336 G>C and rs822337 T>A: Promising Prognostic Markers in Triple Negative Breast Cancer PatientsSemantic proximity Read ↗

Low CYP24A1 mRNA expression and its role in prognosis of breast cancerSemantic proximity Read ↗

CD44 gene polymorphisms in breast cancer risk and prognosis: a study in North Indian population.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.